Syon Capital’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Syon Capital's RXRX Position: Q3 2026 in Review
Syon Capital increased its Recursion Pharmaceuticals (RXRX) stake by 9.2% in Q3 2026, buying an estimated $10.4K and bringing the position to 36,456 shares worth $151K. The position accounts for 0.01% of the portfolio, ranked #1065.
Syon Capital first reported a position in RXRX in Q4 2024 and has held it in 5 quarters since. The position peaked at $159K in Q4 2024. 352 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Syon Capital held 36,456 shares of Recursion Pharmaceuticals worth $151K as of Q3 2026.
- Syon Capital bought 3,057 Recursion Pharmaceuticals shares in Q3 2026, an estimated $10.4K.
- Recursion Pharmaceuticals made up 0.01% of Syon Capital's portfolio in Q3 2026, its #1065 holding.
- Syon Capital first reported a position in Recursion Pharmaceuticals in Q4 2024 and has held it in 5 quarters since.
- Syon Capital's Recursion Pharmaceuticals position peaked at $159K in Q4 2024.
- 352 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Syon Capital's 13F filing for Q3 2026, filed 16 Nov 2026.